Advertisement
Loading...

CG Oncology, Inc. Common stock

CGON•NASDAQ
Healthcare
Biotechnology
$67.41
$-6.59(-8.90%)
U.S. Market is Open • 15:42

CG Oncology, Inc. Common stock (CGON) Stock Overview

Explore CG Oncology, Inc. Common stock’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap6.1B
P/E Ratio-31.14
EPS (TTM)$-2.34
ROE-0.23%
Fundamental Analysis

AI Price Forecasts

1 Month$52.70
3 Months$59.15
1 Year Target$64.46

CGON Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of CG Oncology, Inc. Common stock (CGON) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 52.84, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $64.46.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -31.14 and a market capitalization of 6.1B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-6.03%
5-Day Change
0.92%
1-Month Change
3.35%
3-Month Change
35.02%
6-Month Change
69.56%
Year-to-Date (YTD) Change
67.47%
1-Year Change
187.69%
3-Year Change
87.07%
5-Year Change
87.07%
All-Time (Max) Change
87.07%

Contact Information

https://cgoncology.com
+1 949 354 1630
400 Spectrum Center Drive, Irvine, DE, NaN

Company Facts

113 Employees
IPO DateJan 25, 2024
CountryUS
Actively Trading

Frequently Asked Questions